Related Experiment Video

Updated: Mar 30, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.7K

Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression

Yan Duan1, Winnie Wong1, Sonja Courtney Chua1

  • 1Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore 117543, Republic of Singapore.

International Journal of Oncology
|November 18, 2015
PubMed

Insights

Tyrosine 3 (Tyro3) is upregulated in hepatocellular carcinoma (HCC), promoting tumor growth and liver dysfunction. Inhibiting Tyro3 may offer new therapeutic strategies for HCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) pathogenesis involves various tyrosine kinases, but a dominant therapeutic target remains elusive.
  • The TAM receptor family, including Tyro3, Axl, and Mer, plays a role in cancer, yet Tyro3's specific function in HCC is underexplored.

Purpose of the Study:

  • To investigate the role of Tyro3 expression in hepatocellular carcinoma (HCC).
  • To correlate Tyro3 expression with HCC phenotypes and clinical data.
  • To evaluate the functional impact of Tyro3 on HCC cell proliferation and marker expression.

Main Methods:

  • Quantification of Tyro3 expression in cancerous and adjacent normal tissues from 55 HCC patients.
  • Correlation analysis of Tyro3 expression with clinical data, including alpha-fetoprotein (AFP) and alanine transaminase (ALT).
  • In vitro studies involving HCC cell lines, including gene silencing of Tyro3 in Hep3B cells to assess effects on proliferation, ERK phosphorylation, cyclin D1, and AFP expression.

Main Results:

  • Tyro3 was significantly upregulated (>2-fold) in approximately 42% of HCC tumor tissues compared to normal tissues.
  • Higher Tyro3 expression correlated with elevated levels of the tumor marker AFP, increased tumor diameter, and higher ALT.
  • Gene silencing of Tyro3 in HCC cells reduced proliferation, ERK phosphorylation, cyclin D1 expression, and suppressed AFP expression.

Conclusions:

  • Tyro3 is frequently overexpressed in HCC and is associated with aggressive tumor phenotypes and liver dysfunction.
  • Tyro3 plays a critical role in maintaining HCC cell proliferation and AFP expression.
  • Targeting Tyro3 signaling represents a potential therapeutic strategy for HCC treatment, particularly in tumors with high Tyro3 expression.

More Related Videos

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.1K
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K